TG Therapeutics, Inc.TGTXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank57
3Y CAGR-8.2%
5Y CAGR-32.2%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-8.2%/yr
vs +25.0%/yr prior
5Y CAGR
-32.2%/yr
Recent acceleration
Acceleration
-33.2pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$79.15M-56.0%
2024$179.89M+93.6%
2023$92.93M-9.2%
2022$102.30M-65.8%
2021$298.89M-46.0%
2020$553.44M+391.3%
2019$112.64M+168.5%
2018$41.96M-26.0%
2017$56.72M+126.6%
2016$25.03M-